Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

This grant invites applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.

Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology.

Funding: $300,000 per year

Duration: 3 years

Research Autority due date: 10 days prior to submission 

LOI (encouraged) due dates: 22.1.21, 27.4.21, 29.8.21

Full proposal due dates: 22.2.21, 27.5.21, 29.9.21